This publication has 12 references indexed in Scilit:

• A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins
  The Journal of Infectious Diseases, 2013
• Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasm
  Journal of Neural Transmission, 2013
• A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin®: A new botulinum neurotoxin A
  Parkinsonism & Related Disorders, 2012
• Efficacy and Safety of Long-term Botulinum Toxin Treatment in Craniocervical Dystonia: A Systematic Review
  Neurotoxicity Research, 2012
• Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial
  Movement Disorders, 2011
• Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm
  Journal of Neural Transmission, 2010
• Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]
  Neurology, 2008
• Dystonia
  New England Journal of Medicine, 2006
• The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument
  PharmacoEconomics, 1993